EV/EBITDA
31.03
-62.80-66.93%
Thu, 28 Nov 2024 00:59:48 GMT
Summary:
Outlook Therapeutics EV/EBITDA is currently 31.03, with a fall of -62.80 (-66.93%) during the most recent trading day. Over the past year, it has increased by +33.39 (+1414.83%). OTLK EV/EBITDA is now -81.61% below its all-time high of 168.72.OTLK EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OTLK EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -66.9% |
| 1 m1 month | -68.8% |
| 3 m3 months | -77.4% |
| 6 m6 months | +1216.2% |
| ytdytd | +1346.2% |
| 1 y1 year | +1414.8% |
| 5 y5 years | +2821.9% |
OTLK EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 123.04 | -74.8% | 31.03 | at low |
| 3 m | 3 months | 145.39 | -78.7% | 31.03 | at low |
| 6 m | 6 months | 168.72 | -81.6% | -2.84 | +1192.6% |
| 1 y | 1 year | 168.72 | -81.6% | -5.65 | +649.2% |
| 3 y | 3 years | 168.72 | -81.6% | -8.62 | +460.0% |
| 5 y | 5 years | 168.72 | -81.6% | -16.32 | +290.1% |
| alltime | all time | 168.72 | -81.6% | -16.32 | +290.1% |
Outlook Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 31.03(-1346.2%) |
| 2023 | -2.49(-35.2%) |
| 2022 | -3.84(-22.7%) |
| 2021 | -4.97(+0.4%) |
| Date | Value |
|---|---|
| 2020 | -4.95(+438.0%) |
| 2019 | -0.92(-52.8%) |
| 2018 | -1.95(-15.9%) |
| 2017 | -2.32(+48.7%) |
| 2016 | -1.56 |
FAQ
- What is Outlook Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Outlook Therapeutics?
- What is OTLK EV/EBITDA year-to-date change?
- What is Outlook Therapeutics EV/EBITDA year-on-year change?
What is Outlook Therapeutics EV/EBITDA?
The current EV/EBITDA of OTLK is 31.03
What is the all time high EV/EBITDA for Outlook Therapeutics?
Outlook Therapeutics all-time high EV/EBITDA is 168.72
What is OTLK EV/EBITDA year-to-date change?
Outlook Therapeutics EV/EBITDA has changed by +33.52 (+1346.18%) since the beginning of the year
What is Outlook Therapeutics EV/EBITDA year-on-year change?
Over the past year, OTLK EV/EBITDA has changed by +33.39 (+1414.83%)